合成目标产物 3,3-Bis(P-Hydroxyphenyl)Oxindole 主要起始原料 Isatin And Phenol
(文献来源)合成步骤主要原料 Isatin 和 Phenol
📜3,3-Dichloroindolin-2-One,苯酚 反应生成3,3-二(4-羟基苯基)-2(3H)-吲哚酮 参考文献:Inagaki,Yakugaku Zasshi/journal Of The Pharmaceutical Society Of Japan,1933,Vol. 53,P. 686,696;Dtsch.Ref.S.133 标题:Inagaki,Yakugaku Zasshi/journal Of The Pharmaceutical Society Of Japan,1933,Vol. 53,P. 686,696;Dtsch.Ref.S.133
专利号:US-2007299102-A1 优先权日:2004-04-08 标题:Diphenyl Ox-Indol-2-One Compounds and Their Use in the Treatment of Cancer 发明人:FELDING JAKOB; PEDERSEN HANS C; KROG-JENSEN CHRISTIAN; PRAESTEGAARD MORTEN; BUTCHER STEVEN P; LINDE VIGGO; COULTER THOMAS S; MONTALBETTI CHRISTIAN; UDDIN MOHAMMED; REIGNIER SERGE 权利人:TOPOTARGET AS 摘要:The present invention relates to substituted 3,3-diphenyl-1,3-dihydro-indol-2-one compounds, and the use of such compounds for the preparation of a medicament for the treatment of cancer in a mammal. It is postulated that treatment of cancers is achieved in which inhibition of protein synthesis and/or inhibition of activation of the mTOR pathway is an effective method for reducing cell growth. Examples of such cancers are breast cancer, renal cancer, multiple myeloma, leukemia, glia blastoma, rhabdomyosarcoma, prostate, soft tissue sarcoma, colorectal sarcoma, gastric carcinoma, head and neck squamous cell carcinoma, uterine, cervical, melanoma, lymphoma, and pancreatic cancer. A particular subclass of compounds are represented by the formula (II) n n nwherein at least one of X 1 and X 2 is a heteroatom substituent, e.g. 6-chloro-3,3-bis-(4-hydroxy-phenyl)-7-methyl-1,3-dihydro-indol-2-one.
专利号:CN-106188617-B 优先权日:2016-07-19 标题 :A kind of cardanol-based ether-type plasticizer and its synthesis method and application
专利号:CN-118006831-A 优先权日:2024-03-13 标题 :SNP markers of cabbage wax synthesis gene BoKCS-like and its application
1: Trojel-Hansen C, Erichsen KD, Christensen MK, Jensen PB, Sehested M, Nielsen SJ. Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential. Cancer Chemother Pharmacol. 2011 Jul;68(1):127-38. doi: 10.1007/s00280-010-1453-3. Epub 2010 Sep 18. doi: 10.1002/cam4.107. Epub 2013 Jul 23. 4: Uddin MK, Reignier SG, Coulter T, Montalbetti C, Grånäs C, Butcher S, Krog-Jensen C, Felding J. Syntheses and antiproliferative evaluation of oxyphenisatin derivatives. Bioorg Med Chem Lett. 2007 May 15;17(10):2854-7. Epub 2007 Feb 25. Russian. Review. French. Spanish. 12: Sund RB, Hol L, Storbråten A. Studies in the rat on the absorption, biliary excretion, laxative action and interference with intestinal transport of some oxyphenisatin derivatives. Acta Pharmacol Toxicol (Copenh). 1979 Apr;44(4):251-9. Review.
合成参考文献
摘要:S109 | PARCEDC | List of 7074 potential endocrine disrupting compounds (EDCs) by PARC T4.2 | DOI:10.5281/zenodo.10944198 参考文献:10.1007/bf01476572 摘要:Ewe K, Wanitschke R. The effect of cathartic agents on transmucosal electrical potential difference in the human rectum. Klin Wochenschr. 1980 Mar 17;58(6):299–306. doi: 10.1007/bf01476572.